XML 49 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2016
Stockholders' Equity  
Schedule of key assumptions to determine fair value of options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

 

June 30, 

 

June 30, 

 

 

 

    

2016

    

2015

    

2016

    

2015

 

 

Average volatility

 

33.0

%  

24.9

%  

30.4

%

27.1

%

 

Risk-free interest rate

 

0.9

%  

1.1

%  

1.5

%

1.2

%

 

Weighted-average expected life in years

 

3.0

 

3.2

 

5.5

 

4.5

 

 

Dividend yield rate

 

 —

%  

 —

%  

 —

%

 —

%

 

 

Schedule of the summary of option activity under all plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

Weighted-Average

 

Remaining

 

Aggregate

 

 

 

 

 

Exercise

 

Contractual

 

Intrinsic

 

 

 

Options

 

Price

 

Term (Years)

 

Value(1)

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Outstanding as of December 31, 2015

    

12,240,467

    

$

15.41

    

    

    

 

    

 

Options granted

 

2,382,036

 

 

12.15

 

 

 

 

 

 

Options exercised

 

(280,303)

 

 

11.61

 

 

 

 

 

 

Options cancelled

 

(126,225)

 

 

13.46

 

 

 

 

 

 

Options expired

 

(233,136)

 

 

24.11

 

 

 

 

 

 

Outstanding as of June 30, 2016

 

13,982,839

 

$

14.80

 

4.62

 

$

37,001

 

Exercisable as of June 30, 2016

 

8,039,685

 

$

16.02

 

3.25

 

$

19,081

 


The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the estimated fair value of the Company’s common stock for those awards that have an exercise price below the estimated fair value at June 30, 2016.

Schedule of information relating to options grants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2016

    

2015

    

2016

    

2015

 

 

 

(in thousands, except per share data)

 

Weighted-average grant date fair value

 

$

3.88

 

$

2.89

 

$

3.40

 

$

3.44

 

Intrinsic value of options exercised

 

 

967

 

 

2,264

 

 

982

 

 

2,453

 

Cash received

 

 

3,149

 

 

9,531

 

 

3,253

 

 

10,441

 

Total fair value of the options vested during the year

 

 

2,000

 

 

1,112

 

 

5,260

 

 

2,536

 

 

Schedule of the summary of nonvested options status

 

 

 

 

 

 

 

 

    

 

    

Weighted-Average

 

 

 

 

 

Grant Date

 

 

 

Options

 

Fair Value

 

Nonvested as of December 31, 2015

 

5,202,095

 

$

3.44

 

Options granted

 

2,382,036

 

 

3.40

 

Options vested

 

(1,514,752)

 

 

3.47

 

Options forfeited

 

(126,225)

 

 

4.65

 

Nonvested as of June 30, 2016

 

5,943,154

 

 

3.39

 

 

Schedule of information relating to RSU grants and deliveries

 

 

 

 

 

 

 

 

 

 

 

 

Total Fair Market

 

 

 

 

 

Value of RSUs

 

 

 

 

 

Issued

 

 

 

Total RSUs

 

as

 

 

    

Issued

    

Compensation(1)

 

 

 

 

 

(in thousands)

 

RSUs outstanding at December 31, 2015

 

866,540

 

 

 

 

RSUs granted

 

726,830

 

$

8,549

 

RSUs forfeited

 

(39,070)

 

 

 

 

Common stock delivered

 

(207,569)

 

 

 

 

RSUs surrendered for taxes

 

(102,641)

 

 

 

 

RSUs outstanding at June 30, 2016

 

1,244,090

 

 

 

 


The total fair market value is derived from the number of RSUs granted times the current stock price on the date of grant.

Schedule of recorded share-based compensation expense under all plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

 

2016

 

2015

 

2016

 

2015

 

 

 

(in thousands)

 

Cost of revenues

    

$

771

    

$

730

    

$

1,570

    

$

1,218

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, distribution and marketing

 

 

65

 

 

59

 

 

131

 

 

99

 

General and administrative

 

 

3,100

 

 

2,650

 

 

5,746

 

 

4,140

 

Research and development

 

 

262

 

 

261

 

 

602

 

 

473

 

Total share-based compensation

 

$

4,198

 

$

3,700

 

$

8,049

 

$

5,930

 

 

Schedule of changes in stockholders' equity

 

 

 

 

 

 

 

 

Six Months

 

 

 

Ended

 

 

 

June 30, 

 

 

    

2016

 

 

 

(in thousands)

 

 

 

 

 

 

Stockholders’ equity as of December 31, 2015

 

$

295,510

 

 Net income

 

 

9,384

 

 Accumulated other comprehensive loss

 

 

(215)

 

 Exercise of stock options

 

 

3,253

 

 Issuance of common stock to employees under ESPP

 

 

915

 

 Nonemployee share-based compensation expense

 

 

815

 

 Employee share-based compensation expense

 

 

7,234

 

 Repurchase of common stock(1)

 

 

(1,242)

 

 Purchase of treasury stock

 

 

(8,190)

 

Stockholders’ equity as of June 30, 2016

 

$

307,464

 


(1)

Repurchase of common stock relating to the tax withholding of equity award settlements.